Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,740,000 | 5,100,000 | 6,218,000 | 6,327,000 | 7,556,000 |
| Marketable Securities | 1,508,000 | 1,323,000 | 1,732,000 | 1,675,000 | 1,044,000 |
| Receivables | 4,677,000 | 4,758,000 | 4,999,000 | 5,048,000 | 4,753,000 |
| Inventories | 1,427,000 | 1,444,000 | 1,630,000 | 1,756,000 | 1,789,000 |
| TOTAL | $15,547,000 | $16,187,000 | $16,290,000 | $16,791,000 | $16,622,000 |
| Non-Current Assets | |||||
| PPE Net | 2,612,000 | 2,604,000 | 2,638,000 | 2,618,000 | 2,597,000 |
| Investments And Advances | 2,123,000 | 1,783,000 | 1,378,000 | 1,400,000 | 387,000 |
| Intangibles | 44,119,000 | 44,313,000 | 44,770,000 | 44,957,000 | 32,786,000 |
| Other Non-Current Assets | 1,263,000 | 1,212,000 | 1,550,000 | 1,445,000 | 1,328,000 |
| TOTAL | $50,117,000 | $49,912,000 | $50,336,000 | $50,420,000 | $37,098,000 |
| Total Assets | $65,664,000 | $66,099,000 | $66,626,000 | $67,211,000 | $53,720,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 425,000 | 402,000 | 26,000 | 517,000 | 2,423,000 |
| Accounts payable and accrued liabilities | 8,419,000 | 9,379,000 | 9,077,000 | 8,755,000 | 8,239,000 |
| TOTAL | $8,844,000 | $9,781,000 | $9,103,000 | $9,272,000 | $10,662,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,526,000 | 36,440,000 | 37,284,000 | 37,328,000 | 29,490,000 |
| Other Non-Current Liabilities | 8,499,000 | 8,352,000 | 7,646,000 | 7,791,000 | 3,513,000 |
| TOTAL | $51,822,000 | $51,682,000 | $51,054,000 | $52,299,000 | $38,415,000 |
| Total Liabilities | $60,666,000 | $61,463,000 | $60,157,000 | $61,571,000 | $49,077,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,591,540 | 1,593,920 | 1,625,099 | 1,628,542 | 1,617,359 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | 5,063,000 | 4,378,000 | 4,011,000 | 3,349,000 | 2,673,000 |
| Other shareholders' equity | -2,542,000 | -2,586,000 | -2,340,000 | -2,390,000 | -2,423,000 |
| TOTAL | $4,998,000 | $4,636,000 | $6,469,000 | $5,640,000 | $4,643,000 |
| Total Liabilities And Equity | $65,664,000 | $66,099,000 | $66,626,000 | $67,211,000 | $53,720,000 |